MarketCap
Facebook
X
Telegram
American Well Corporation EPS Ratio | AMWL
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio American Well Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.96 | -13.9 | -47.5 | -19.7 | -0.69 | -2.27 | -2.12 | -1.3 | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.69 | -47.5 | -11.7 |
Quarterly EPS Ratio American Well Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.67 | -0.59 | -0.66 | -1.52 | -2 | -1.24 | -1.19 | -2.75 | -2.87 | -3.36 | -4.94 | -3.22 | -9.54 | -6.53 | -1.42 | -18.9 | -0.25 | -0.25 | -0.26 | -0.18 | -0.2 | -0.15 | -0.16 | 1.11 | -0.92 | -1.99 | -0.58 | - | -0.57 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.11 | -18.9 | -2.35 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Health information services industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
HealthEquity
HQY
|
2.5 | $ 103.6 | 0.13 % | $ 8.92 B |  USA |
 |
Omnicell
OMCL
|
0.04 | $ 37.35 | -1.77 % | $ 1.72 B | USA |
 |
Progyny
PGNY
|
0.15 | $ 34.88 | 1.48 % | $ 2.97 B | USA |
 |
Schrödinger
SDGR
|
-1.41 | $ 29.8 | 3.58 % | $ 2.19 B | USA |
 |
Teladoc Health
TDOC
|
-1.14 | $ 8.85 | -6.2 % | $ 1.56 B | USA |
 |
Computer Programs and Systems
CPSI
|
0.29 | - | 4.4 % | $ 133 M | USA |
 |
Phreesia
PHR
|
0.04 | $ 12.62 | -0.71 % | $ 754 M | USA |
 |
Akerna Corp.
KERN
|
-0.17 | - | - | $ 161 M | USA |
 |
MTBC
MTBC
|
0.1 | - | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
0.22 | - | - | $ 2.33 B | USA |
 |
Streamline Health Solutions
STRM
|
-2.53 | - | - | $ 21.4 M | USA |
 |
Signify Health
SGFY
|
-3.27 | - | -0.02 % | $ 7.21 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-6.07 | - | - | $ 255 M | USA |
 |
Change Healthcare
CHNG
|
-0.18 | - | - | $ 9.03 B | USA |
 |
OptimizeRx Corporation
OPRX
|
0.28 | $ 8.65 | -0.17 % | $ 161 M | USA |
 |
Cerner Corporation
CERN
|
1.86 | - | - | $ 27.9 B | USA |
 |
Veeva Systems
VEEV
|
5.55 | $ 303.83 | -2.03 % | $ 49.7 B | USA |
 |
SCWorx Corp.
WORX
|
-0.61 | $ 7.25 | 31.34 % | $ 52.7 M | USA |
 |
Zhongchao
ZCMD
|
-1.85 | $ 0.96 | -0.08 % | $ 3.28 M |  China |
 |
HealthStream
HSTM
|
0.61 | $ 28.84 | -1.76 % | $ 866 M | USA |
 |
Accolade
ACCD
|
-1.33 | - | 0.29 % | $ 206 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
-2.7 | - | -10.39 % | $ 886 M | USA |
 |
NantHealth
NH
|
-8.8 | - | -46.64 % | $ 10.4 M | USA |
 |
Covetrus
CVET
|
-0.39 | - | - | $ 2.94 B | USA |
 |
NextGen Healthcare
NXGN
|
-0.04 | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
-2.02 | - | - | $ 3.37 B | USA |
 |
iCAD
ICAD
|
-0.21 | - | - | $ 102 M | USA |
 |
R1 RCM
RCM
|
-1.86 | - | - | $ 3.81 B | USA |
 |
10x Genomics
TXG
|
-0.35 | $ 58.86 | 1.38 % | $ 7.34 B | USA |
 |
Evolent Health
EVH
|
-3.84 | $ 4.58 | 0.77 % | $ 523 M | USA |
 |
GoodRx Holdings
GDRX
|
0.09 | $ 3.52 | 0.86 % | $ 1.25 B | USA |
 |
Health Catalyst
HCAT
|
-2.55 | $ 1.47 | -2.0 % | $ 103 M | USA |